Top drug lobbyist to depart PhRMA at year end
The announcement of Steve Ubl’s departure, disclosed during a board call, caps a decade atop the brand-name drug lobby.
The announcement of Steve Ubl’s departure, disclosed during a board call, caps a decade atop the brand-name drug lobby.